The potential role of gut microbiota-derived metabolites as regulators of metabolic syndrome-associated mitochondrial and endolysosomal dysfunction in Alzheimer’s disease

참고문헌 (137)

1. Gustavsson, A., "Global estimates on the number of persons across the Alzheimer’s disease continuum", Alzheimers Dement, 19, pp.658~670 (2023)
2. Bellenguez, C., "New insights into the genetic etiology of Alzheimer’s dis ease and related dementias", Nat. Genet, 54, pp.412~436 (2022)
3. Scheltens, P., "Alzheimer’s disease", Lancet, 397, pp.1577~1590 (2021)
4. van der Lee, S. J., "The effect of APOE and other common genetic variants on the onset of Alzheimer’s disease and dementia : a community-based cohort study", Lancet Neurol, 17, pp.434~444 (2018)
5. Santiago, J. A., "Diabetes : a tipping point in neurodegenerative diseases", Trends Mol. Med, 29, pp.1029~1044 (2023)
6. Lee, H. J., "Enhancing the therapeutic efficacy of mesenchymal stem cell transplantation in diabetes : amelioration of mitochondrial dysfunction-induced senescence", Biomed. Pharmacother, 168, pp.115759~ (2023)
7. Gilleron, J., "Endosomal trafficking in metabolic homeostasis and diseases", Nat. Rev. Endocrinol, 19, pp.28~45 (2023)
8. Wilson, D. M., "Hallmarks of neurodegenerative diseases", Cell, 186, pp.693~714 (2023)
9. Gao, S., "Genetic variation within endolysosomal system is associated with late-onset Alzheimer’s disease", Brain, 141, pp.2711~2720 (2018)
10. Deus, C. M., "Mitochondria-lysosome crosstalk: from physiology to neurodegeneration", Trends Mol. Med, 26, pp.71~88 (2020)
11. Ferreiro, A. L., "Gut microbiome composition may be an indicator of pre clinical Alzheimer’s disease", Sci. Transl. Med, 15, pp.eabo2984~ (2023)
12. Chandra, S., "The gut microbiome in Alzheimer’s disease : what we know and what remains to be explored", Mol. Neurodegener, 18, pp.1~21 (2023)
13. Yuan, X., "Functional and metabolic alterations of gut microbiota in children with new-onset type 1 diabetes", Nat. Commun, 13, pp.6356~ (2022)
14. Cho, J. H., "Sodium butyrate ameliorates high glucose-suppressed neuronal mitophagy by restoring PRKN expression via inhibiting the RELA-HDAC8 com plex", Autophagy, 20, pp.1505~1522 (2024)
15. Aaldijk, E., "The role of serotonin within the microbiota-gut-brain axis in the development of Alzheimer’s disease : a narrative review", Ageing Res. Rev, 75, pp.101556~ (2022)
16. Nianogo, R. A., "Risk factors associated with Alzheimer disease and related dementias by sex and race and ethnicity in the US", JAMA Neurol, 79, pp.584~591 (2022)
17. Ezkurdia, A., "Metabolic syndrome as a risk factor for Alzheimer’s disease: a focus on insulin resistance", Int. J. Mol. Sci, 24, pp.4354~ (2023)
18. Lee, H. J., "High glucose upregulates BACE1-mediated Aβ production through ROS-dependent HIF-1α and LXRα", ABCA1-regulated lipid raft reorgani zation in SK-N-MC cells, 2016, pp.6, 36746~
19. Wang, W., "Mitochondriadysfunction inthe pathogenesis of Alzheimer’s disease : recent advances", Mol. Neurodegener, 15, pp.30~ (2020)
20. Al-Kuraishy, H. M., "The link between metabolic syndrome and Alzheimer disease : a mutual rela tionship and long rigorous investigation", Ageing Res. Rev, 91, pp.102084~ (2023)
21. Huang, J. -r, "Urolithin A ameliorates obesity-induced metabolic cardio myopathy in mice via mitophagy activation", Acta Pharm. Sin, 44, pp.321~331 (2023)
22. de Mello, A. H., "Mitochondrial dys function in obesity", Life Sci, 192, pp.26~32 (2018)
23. Onphachanh, X., "Enhancement of high glucose-induced PINK1 expression by melatonin stimulates neuronal cell survival : involvement of MT2", Akt, J. Pineal Res, pp.2017, 63[DOI]
24. Choi, G. E., "Glucocorticoid impairs mitochondrial quality control in neurons", Neurobiol. Dis, 152, pp.105301~ (2021)
25. Lim, J. R., "Ethanol-activated CaMKII signaling induces neuronal apoptosis through Drp1-mediated excessive mitochondrial fission and JNK1-dependent NLRP3 inflammasome activation", Cell Commun. Signal, 18, pp.123~ (2020)
26. Lee, H. J., "Urolithin A suppresses high glucose-induced neuronal amyloi dogenesis by modulating TGM2-dependent ER-mitochondria contacts and calcium homeostasis", Cell Death Differ, 28, pp.184~202 (2021)
27. Peric, A., "Early etiology of Alzheimer’s disease: tipping the balance toward autophagy or endosomal dysfunction?", Acta Neuropathol, 129, pp.363~381 (2015)
28. Nixon, R. A., "Amyloid precursor protein and endosomal-lysosomal dysfunction in Alzheimer’s disease : inseparable partners in a multifactorial disease", FASEB J, 31, pp.2729~2743 (2017)
29. Chae, C. W., "High glucose-mediated PICALM and mTORC1 modulate pro cessing of amyloid precursor protein via endosomal abnormalities", Br. J. Pharm, 177, pp.3828~3847 (2020)
30. Tessneer, K. L., "Rab5 activity regulates GLUT4 sorting into insulin-responsive and non-insulin-responsive endosomal compartments : a potential mechanism for development of insulin resistance", Endocrinology, 155, pp.3315~3328 (2014)
31. Chae, C. W., "High glucose-mediated VPS26a down-regulation dysregulates neuronal amyloid precursor protein processing and tau phosphorylation", Br. J. Pharm, 179, pp.3934~3950 (2022)
32. Luo, X., "Obesity induces preadipocyte CD36 expression promoting inflammation via the disruption of lysosomal calcium homeostasis and lyso some function", EBioMedicine, 56, pp.102797~ (2020)
33. Chae, C. W., "TRIM16-mediated lysophagy suppresses high-glucose accumulated neuronal Aβ", Autophagy, 19, pp.2752~2768 (2023)
34. Grant, B. D., "Pathways and mechanisms of endocytic recycling", Nat. Rev. Mol. Cell Biol, 10, pp.597~608 (2009)
35. Satoh, A. O., "Interaction between PI3K and the VDAC2 channel tethers Ras PI3K-positive endosomes to mitochondria and promotes endosome maturation", Cell Rep, 42, pp.112229~ (2023)
36. Wu, K. K. L., "A new role of the early endosome in restricting NLRP3 inflammasome via mitophagy", Autophagy, 18, pp.1475~1477 (2022)
37. Todkar, K., "Mitochondrial interaction with the endo somal compartment in endocytosis and mitochondrial transfer", Mitochondrion, 49, pp.284~288 (2019)
38. Wong, Y. C., "Mitochondria-lysosome contacts regulate mitochondrial fission via RAB7 GTP hydrolysis", Nature, 554, pp.382~386 (2018)
39. Cisneros, J., "Mitochondria lysosome contact site dynamics and misregulation in neurodegenerative dis eases", Trends Neurosci, 45, pp.312~322 (2022)
40. Lin, K., "Gut and obesity", metabolic disease : focus on microbiota metabolites, 2022, pp.3, e171~
41. Fan, Y., "Gut microbiota in human metabolic health and disease", Nat. Rev. Microbiol, 19, pp.55~71 (2021)
42. Scheithauer, T. P. M., "Gut microbiota as a trigger for metabolic inflam mation in obesity and type 2 diabetes", Front. Immunol, 11, pp.571731~ (2020)
43. Hosomi, K., "Oral administration of Blautia wexlerae ameliorates obesity and type 2 diabetes via metabolic remodeling of the gut microbiota", Nat. Commun, 13, pp.4477~ (2022)
44. Hossain, I., "Evaluating gut microbiota modification as a next-generation therapy for obesity and diabetes", Curr. Diabetes Rev, 20, pp.e150523216913~ (2023)
45. Suriano, F., "Fat and not sugar as the determining factor for gut microbiota changes, obesity, and related metabolic disorders in mice", Am. J. Physiol. Endocrinol. Metab, 324, pp.E85~e96 (2023)
46. Wang, Y., "The gut microbiota reprograms intestinal lipid metabolism through long noncoding RNA Snhg9", Science, 381, pp.851~857 (2023)
47. Jha, S. K., "Linking mitochondrial dysfunction, metabolic syndrome and stress signaling in Neurodegeneration", Biochim. Biophys. Acta Mol. Basis Dis, 1863, pp.1132~1146 (2017)
48. Atlante, A., "Dysfunction of mitochondria in Alzheimer’s disease : ANT and VDAC interact with toxic proteins and aid to determine the fate of brain cells", Int. J. Mol. Sci, 23, pp.7722~ (2022)
49. Du, H., "Mitochondrial permeability transition pore in Alzheimer’s disease : cyclophilin D and amyloid beta", Biochim. Biophys. Acta, 1802, pp.198~204 (2010)
50. Bobba, A., "Mitochondrial respiratory chain Complexes I and IV are impaired by β-amyloid via direct interaction and through Complex I-dependent ROS production, respectively", Mitochondrion, 13, pp.298~311 (2013)
51. Hansson Petersen, C. A., "The amyloid β-peptide is imported into mito chondria via the TOM import machinery and localized to mitochondrial cristae", Proc. Natl Acad. Sci, 105, pp.13145~13150 (2008)
52. Arbel-Ornath, M., "Soluble oligomeric amyloid-β induces calcium dysho meostasis that precedes synapse loss in the living mouse brain", Mol. Neurode gener, 12, pp.27~ (2017)
53. Kim, S. H., "Endolysosomal impairment by binding of amyloid beta or MAPT", Tau to V-ATPase and rescue via the HYAL-CD44 axis in Alzheimer disease, 2023, pp.19, 2318~2337
54. Tong, B. C., "Lysosomal TPCN(two pore segment channel)inhibition ameliorates β-amyloid pathology and mitigates memory impairment in Alz heimer disease", Autophagy, 18, pp.624~642 (2022)
55. Chambraud, B., "Decrease of neuronal FKBP4", FKBP52 modulates perinuclear lysosomal positioning and MAPT, Tau-induced pro teotoxic stress, pp.Autophagy, 2021[DOI]
56. Ma, L., "The potential mechanism of gut microbiota-microbial metabolites mitochondrial axis in progression of diabetic kidney disease", Mol. Med, 29, pp.148~ (2023)
57. Pappolla, M. A., "Indoles as essential mediators in the gut-brain axis. Their role in Alzheimer’s disease", Neurobiol. Dis, 156, pp.105403~ (2021)
58. Alegre, G. F. S., "NAD+precursors nicotinamide mononucleotide(NMN)and nicotinamide riboside(NR) : potential dietary contribution to health", Curr. Nutr. Rep, 12, pp.445~464 (2023)
59. Li, F., "The intestinal microbial metabolite nicotinamide n-oxide prevents herpes simplex encephalitis via activating mitophagy in microglia", Gut Microbes, 14, pp.2096989~ (2022)
60. Chu, X., "Nicotinamide adenine dinucleotide supplementation drives gut microbiota variation in Alzheimer’s mouse model", Front. Aging Neurosci, 14, pp.993615~ (2022)
61. Yagi, M., "Mitochondrial translation deficiency impairs NAD+-mediated lysosomal acidification", EMBO J, 40, pp.e105268~ (2021)
62. Wang, Z., "Nicotinic acid supplementation contributes to the amelioration of Alzheimer’s disease in mouse models", Ann. Transl. Med, 10, pp.1049~ (2022)
63. Bermudez-Martin, P., "The microbial metabolite p-Cresol induces autistic-like behaviors in mice by remodeling the gut microbiota", Microbiome, 9, pp.157~ (2021)
64. Fromentin, S., "Microbiome and metabolome features of the cardiometa bolic disease spectrum", Nat. Med, 28, pp.303~314 (2022)
65. Tevzadze, G., "Gut neurotoxin p-cresol induces differential expression of GLUN2B and GLUN2A subunits of the NMDA receptor in the hippocampus and nucleus accumbens in healthy and audiogenic seizure-prone rats", AIMS Neurosci, 7, pp.30~42 (2020)
66. Madeo, F., "Spermidine in health and disease", Science, 359, pp.eaan2788~ (2018)
67. Freitag, K., "Spermidine reduces neuroinflammation and soluble amyloid βin an Alzheimer’s disease mouse model", J. Neuroinflammation, 19, pp.172~ (2022)
68. Chang, C. H., "D-glutamate and gut microbiota in Alz heimer’s disease", Int. J. Mol. Sci, 21, pp.2676~ (2020)
69. Wilden, A. R., "Glutamine dependent lysosome homeostatic changes induced by starvation and lysosome inhibition", Biochim. Biophys. Acta Mol. Cell Res, 1865, pp.1356~1367 (2018)
70. Palomo-Buitrago, M. E., "Glutamate interactions with obesity, insulin resis tance, cognition and gut microbiota composition", Acta Diabetol, 56, pp.569~579 (2019)
71. Fusco, W., "Short-chain fatty-acid-producing bacteria : Key components of the human gut microbiota", Nutrients, 15, pp.2211~ (2023)
72. Kim, S. Y., "Sodium butyrate inhibits high cholesterol-induced neuronal amyloidogenesis by modulating NRF2 stabilization-mediated ROS levels : invol vement of NOX2 and SOD1", Cell Death Dis, 11, pp.469~ (2020)
73. Cheng, Y., "Propionate relieves pentylenetetrazol-induced seizures, con sequent mitochondrial disruption, neuron necrosis and neurological deficits in mice", Biochem. Pharm, 169, pp.113607~ (2019)
74. Silva, Y. P., "The role of short-chain fatty acids from gut microbiota in gut-brain communication", Front. Endocrinol, 11, pp.25~ (2020)
75. Sanna, S., "Causal relationships among the gut microbiome, short-chain fatty acids and metabolic diseases", Nat. Genet, 51, pp.600~605 (2019)
76. Takeuchi, T., "Fatty acid overproduction by gut commensal microbiota exacerbates obesity", Cell Metab, 35, pp.361~375 (2023)
77. Pujo, J., "Bacteria-derived long chain fatty acid exhibits anti-inflammatory properties in colitis", Gut, 70, pp.1088~1097 (2021)
78. Ran-Ressler, R. R., "Branched-chain fatty acids in the neonatal gut and estimated dietary intake in infancy and adulthood", Nestle Nutr. Inst. Workshop Ser, 77, pp.133~143 (2013)
79. Choi, B. S. Y., "Feeding diversified protein sources exacerbates hepatic insulin resistance via increased gut microbial branched-chain fatty acids and mTORC1 signaling in obese mice", Nat. Commun, 12, pp.3377~ (2021)
80. Hemalatha, R., "Effect of probiotic supplementation on total lactobacilli, bifidobacteria and short chain fatty acids in 2-5-year-old children", Micro. Ecol. Health Dis, 28, pp.1298340~ (2017)
81. Wei, M., "A dysregulated bile acid-gut microbiota axis contributes to obesity susceptibility", EBioMedicine, 55, pp.102766~ (2020)
82. MahmoudianDehkordi, S., "Altered bile acid profile associates with cognitive impairment in Alzheimer’s disease-An emerging role for gut microbiome", Alz heimers Dement, 15, pp.76~92 (2019)
83. Luan, H., "Thermal proteome profiling unveils protein targets of deoxycholic acid in living neuronal cells", Adv. Biotechnol, 1, pp.7~ (2023)
84. Carello-Collar, G., "The GABAergic system in Alzheimer’s disease : a sys tematic review with meta-analysis", Mol. Psychiatry, 12, pp.5025~5036 (2023)
85. Loh, J. S., "Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases", Signal. Transduct. Target Ther, 9, pp.37~ (2024)
86. Rezazadeh, H., "Ɣ-aminobutyric acid attenuates insulin resistance in type 2 diabetic patients and reduces the risk of insulin resistance in their offspring", Biomed. Pharmacother, 138, pp.111440~ (2021)
87. Pessione, E., "Lactic acid bacteria contribution to gut microbiota complexity : lights and shadows", Front. Cell Infect. Microbiol, 2, pp.86~ (2012)
88. Wang, G., "Lactic acid bacteria reduce diabetes symptoms in mice by alleviating gut microbiota dysbiosis and inflammation in different manners", Food Funct, 11, pp.5898~5914 (2020)
89. Wang, S. P., "Pivotal roles for pH, lactate, and lactate-utilizing bacteria in the stability of a human colonic microbial ecosystem", mSystems, 5, pp.e00645~00620 (2020)
90. Bourriaud, C., "Lactate is mainly fermented to butyrate by human intestinal microfloras but inter-individual variation is evident", J. Appl. Microbiol, 99, pp.201~212 (2005)
91. Daw, C. C., "Lactate elicits ER-Mitochondrial Mg2+ dynamics to integrate cellular metabolism", Cell, 183, pp.474~489 (2020)
92. Veronese, N., "Magnesium status in Alzheimer’s disease : a systematic review", Am. J. Alzheimers Dis. Other Demen, 31, pp.208~213 (2016)
93. Sun, W., "Lactate is a bridge linking glycolysis and autophagy through lactylation", Autophagy, 19, pp.3240~3241 (2023)
94. D’Amico, D., "Impact of the natural compound urolithin A on health, disease, and aging", Trends Mol. Med, 27, pp.687~699 (2021)
95. Toney, A. M., "Urolithin A, a gut metabolite, improves insulin sensitivity through augmentation of mitochondrial function and biogenesis", Obesity, 27, pp.612~620 (2019)
96. Fang, E. F., "Mitophagy inhibits amyloid-β and tau pathology and reverses cognitive deficits in models of Alzheimer’s disease", Nat. Neurosci, 22, pp.401~412 (2019)
97. Ballesteros-Álvarez, J., "Urolithin A reduces amyloid-β load and improves cognitive deficits uncorrelated with plaque burden in a mouse model of Alzheimer’s disease", Geroscience, 45, pp.1095~1113 (2023)
98. Shan, Z., "Association between microbiota-dependent metabolite trimethylamine-N-oxide and type 2 diabetes", Am. J. Clin. Nutr, 106, pp.888~894 (2017)
99. Dehghan, P., "Gut microbiota‐derived metabolite trimethylamine N‐oxide (TMAO) potentially increases the risk of obesity in adults: an exploratory systematic review and dose‐response meta‐analysis", Obes. Rev, 21, pp.e12993~ (2020)
100. Vogt, N. M., "The gut microbiota-derived metabolite trimethylamine N-oxide is elevated in Alzheimer’s disease", Alzheimers Res. Ther, 10, pp.124~ (2018)
101. Buawangpong, N., "The role of trimethylamine-N-Oxide in the development of Alzheimer’s disease", J. Cell Physiol, 237, pp.1661~1685 (2022)
102. Villard, A., "Microbiota-derived extracellular vesicles and metabolic syndrome", Acta Physiol, 231, pp.e13600~ (2021)
103. Díez-Sainz, E., "Effects of gut microbiota-derived extracellular vesicles on obesity and diabetes and their potential modulation through diet", J. Physiol. Biochem, 78, pp.485~499 (2022)
104. Choi, Y., "Gut microbe-derived extracellular vesicles induce insulin resis tance, thereby impairing glucose metabolism in skeletal muscle", Sci. Rep, 5, pp.15878~ (2015)
105. Gomes, P., "Extracellular vesicles and Alzheimer’s disease in the novel era of precision medicine : implications for disease progression, diagnosis and treat ment", Exp. Neurol, 358, pp.114183~ (2022)
106. Lee, K. E., "The extracellular vesicle of gut microbial Paenalcaligenes hominis is a risk factor for vagus nerve-mediated cognitive impairment", Microbiome, 8, pp.107~ (2020)
107. Kang, S. G., "Effect of gut microbiome-derived metabolites and extracellular vesicles on hepatocyte functions in a gut-liver axis chip", Nano Converg, 10, pp.5~ (2023)
108. Kim, N. Y., "Effect of gut microbiota-derived metabolites and extracellular vesicles on neurodegenerative disease in a gut-brain axis chip", Nano Converg, 11, pp.7~ (2024)
109. Avila-Calderón, E. D., "Outer membrane vesicles of gram-negative bacteria : an outlook on biogenesis", Front. Microbiol, 12, pp.557902~ (2021)
110. Dekkers, K. F., "An online atlas of human plasma metabolite signatures of gut microbiome composition", Nat. Commun, 13, pp.5370~ (2022)
111. Martín, R., "Gnotobiotic rodents: an in vivo model for the study of microbe-microbe interactions", Front. Microbiol, 7, pp.409~ (2016)
112. Kennedy, E. A., "Mouse microbiota models : com paring germ-free mice and antibiotics treatment as tools for modifying gut bacteria", Front. Physiol, 9, pp.1534~ (2018)
113. Puschhof, J., "Intestinal organoid cocultures with microbes", Nat. Protoc, 16, pp.4633~4649 (2021)
114. Ueda, A., "Identification of Faecalibacterium prausnitzii strains for gut microbiome-based intervention in Alzheimer’s-type dementia", Cell Rep. Med, 2, pp.100398~ (2021)
115. Centurion, F., "Nanoencapsulation for probiotic delivery", ACS Nano, 15, pp.18653~18660 (2021)
116. Liu, N., "Mesoporous silica nanoparticle-encapsulated Bifidobacterium attenuates brain Aβ burden and improves olfactory dysfunction of APP", PS1mice by nasal delivery, 2022, pp.20, 439~
117. Liang, B., "The current and future perspectives of postbiotics", Probiotics Antimicrob. Proteins, 15, pp.1626~1643 (2023)
118. Fiedorowicz, M., "Tryptophan and kynurenine pathway metabolites in ani mal models of retinal and optic nerve damage : different dynamics of changes", Front. Physiol, 10, pp.1254~ (2019)
119. Fu, J., "Tauroursodeoxycholic acid protects retinal and visual function in a mouse model of type 1 diabetes", Pharmaceutics, 13, pp.1154~ (2021)
120. Ghoneim, M. A. M., "Effect of polysaccharide from Bacillus subtilis sp. on cardiovascular diseases and athero genic indices in diabetic rats", BMC Complement Alter. Med, 16, pp.112~ (2016)
121. Balaguer, F., "Lipoteichoic acid from Bifidobacterium animalis subsp. lactis BPL1: a novel postbiotic that reduces fat deposition via IGF-1 pathway", Micro. Biotechnol, 15, pp.805~816 (2022)
122. Balzaretti, S., "A novel rhamnose-rich hetero-exopolysaccharide isolated from Lactobacillus paracasei DG activates THP-1 human monocytic cells", Appl Environ. Microbiol, 83, pp.e02702~e02716 (2017)
123. Huang, Y., "Sodium butyrate ameliorates diabetic retinopathy in mice via the regulation of gut microbiota and related short-chain fatty acids", J. Transl. Med, 21, pp.451~ (2023)
124. Magryś, A., "Postbiotic fractions of probiotics Lactobacillus plantarum 299v and Lactobacillus rhamnosus GG show immune-modulating effects", Cells, 12, pp.2538~ (2023)
125. Piqué, N., "Health benefits of heat-killed(tyn dallized)probiotics : an overview", Int. J. Mol. Sci, 20, pp.2534~ (2019)
126. Kircher, B., "Predicting butyrate-and propionate-forming bacteria of gut microbiota from sequencing data", Gut Microbes, 14, pp.2149019~ (2022)
127. Erny, D., "Microbiota-derived acetate enables the metabolic fitness of the brain innate immune system during health and disease", Cell Metab, 33, pp.2260~2276 (2021)
128. Fock, E., "Mechanisms of blood-brain barrier protection by microbiota-derived short-chain fatty acids", Cells, 12, pp.657~ (2023)
129. Hoyles, L., "Metabolic retroconversion of trimethylamine N-oxide and the gut microbiota", Microbiome, 6, pp.73~ (2018)
130. Vizioli, C., "Administration of Bifidobacterium animalis subsp. lactis strain BB 12® in healthy children: characterization, functional composition, and metabo lism of the gut microbiome", Front. Microbiol, 14, pp.1165771~ (2023)
131. Strandwitz, P., "GABA-modulating bacteria of the human gut microbiota", Nat. Microbiol, 4, pp.396~403 (2019)
132. Banerjee, S., "Transcriptomics reveal different metabolic strategies for acid resistance and gamma-aminobutyric acid(GABA)production in select Levi lactobacillus brevis strains", Micro. Cell Fact, 20, pp.173~ (2021)
133. Lyu, C., "Exploring the contributions of two glutamate decarboxylase iso zymes in Lactobacillus brevis to acid resistance and γ-aminobutyric acid pro duction", Micro. Cell Fact, 17, pp.180~ (2018)
134. Mulak, A., "Bile acids as key modulators of the brain-gut-microbiota axis in Alz heimer’s disease", J. Alzheimers Dis, 84, pp.461~477 (2021)
135. Saksena, S., "Upregulation of P-glycoprotein by probiotics in intestinal epithelial cells and in the dextran sulfate sodium model of colitis in mice", Am. J. Physiol. Gastrointest. Liver Physiol, 300, pp.G1115~G1123 (2011)
136. Foley, S. E., "Gut microbiota regulation of P-glycoprotein in the intestinal epithelium in maintenance of homeostasis", Microbiome, 9, pp.183~ (2021)
137. Chiu, C., "P-glycoprotein expression and amyloid accumulation in human aging and Alzheimer’s disease : preliminary observations", Neurobiol. Aging, 36, pp.2475~2482 (2015)

관련 논문AI추천